In vivo evaluation of [(18)F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

Development of hypoxia-targeted therapies has stimulated the search for clinically applicable noninvasive markers of tumour hypoxia. Here, we describe the validation of [(18)F]fluoroetanidazole ([(18)F]FETA) as a tumour hypoxia marker by positron emission tomography (PET). Cellular transport and ret...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barthel, H, Wilson, H, Collingridge, D R, Brown, G, Osman, S, Luthra, S K, Brady, F, Workman, P, Price, P M, Aboagye, E O
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2004
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409496/
https://ncbi.nlm.nih.gov/pubmed/15150578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601862
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados